Nicholas Company, Inc. Eli Lilly & CO Transaction History

Nicholas Company, Inc.

$5.86 Billion
Q3 2024

A detailed history of Nicholas Company, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Nicholas Company, Inc. holds 77,265 shares of LLY stock, worth $57.7 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

77,265

Previous 81,775 5.52%

Holding current value

$57.7 Million

Previous $74 Million 7.54%

% of portfolio

1.17%

Previous 1.26%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $3.48 Million - $4.33 Million	-4,510 Reduced 5.52%	77,265 $68.5 Million
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $1.66 Million - $2.08 Million	-2,290 Reduced 2.72%	81,775 $74 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $8.89 Million - $11.9 Million	-15,020 Reduced 15.16%	84,065 $65.4 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $5,251 - $6,191	-10 Reduced 0.01%	99,085 $57.8 Million
Q3 2023 Feb 13, 2024	SELL	$434.7 - $599.3 $5.65 Million - $7.79 Million	-13,005 Reduced 11.6%	99,095 $53.2 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $5.65 Million - $7.79 Million	-13,005 Reduced 11.6%	99,095 $53.2 Million
Q4 2022 Feb 13, 2024	SELL	$321.55 - $374.67 $11,254 - $13,113	-35 Reduced 0.03%	112,100 $41 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $11,254 - $13,113	-35 Reduced 0.03%	112,100 $41 Million
Q3 2022 Feb 13, 2024	SELL	$296.48 - $337.87 $1.29 Million - $1.47 Million	-4,355 Reduced 3.74%	112,135 $36.3 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $1.29 Million - $1.47 Million	-4,355 Reduced 3.74%	112,135 $36.3 Million
Q2 2022 Feb 13, 2024	SELL	$278.73 - $327.27 $3.27 Million - $3.84 Million	-11,745 Reduced 9.16%	116,490 $37.8 Million
Q2 2022 Jul 26, 2022	SELL	$278.73 - $327.27 $3.27 Million - $3.84 Million	-11,745 Reduced 9.16%	116,490 $37.8 Million
Q1 2022 Feb 13, 2024	BUY	$234.69 - $291.66 $6.84 Million - $8.5 Million	29,140 Added 29.41%	128,235 $36.7 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $12.8 Million - $15.9 Million	-54,570 Reduced 29.85%	128,235 $36.7 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $22,485 - $27,904	-100 Reduced 0.05%	182,805 $50.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $10.7 Million - $13.1 Million	-48,175 Reduced 20.85%	182,905 $42.3 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $18,055 - $23,354	-100 Reduced 0.04%	231,080 $53 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $230,048 - $297,808	-1,400 Reduced 0.6%	231,180 $43.2 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $6.63 Million - $8.77 Million	50,820 Added 27.96%	232,580 $39.3 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $2.24 Million - $2.59 Million	-15,340 Reduced 7.78%	181,760 $26.9 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $11.2 Million - $13.5 Million	-82,380 Reduced 29.48%	197,100 $32.4 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $8.2 Million - $10.1 Million	-68,845 Reduced 19.76%	279,480 $38.8 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $5.77 Million - $7.14 Million	53,950 Added 18.33%	348,325 $45.8 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $31.4 Million - $34.2 Million	294,375 New	294,375 $32.9 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Eli Lilly & CO Transaction History